LVFLX
Price
$12.42
Change
+$0.23 (+1.89%)
Updated
Apr 11 closing price
Net Assets
31.76M
VIVAX
Price
$63.21
Change
+$0.94 (+1.51%)
Updated
Apr 11 closing price
Net Assets
190.51B
Ad is loading...

LVFLX vs VIVAX

Header iconLVFLX vs VIVAX Comparison
Open Charts LVFLX vs VIVAXBanner chart's image
Lord Abbett Focused Large Cap Value R6
Price$12.42
Change+$0.23 (+1.89%)
VolumeN/A
Net Assets31.76M
Vanguard Value Index I
Price$63.21
Change+$0.94 (+1.51%)
VolumeN/A
Net Assets190.51B
LVFLX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LVFLX vs. VIVAX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVFLX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. LVFLX (31.8M). VIVAX pays higher dividends than LVFLX: VIVAX (2.14) vs LVFLX (0.91). LVFLX was incepted earlier than VIVAX: LVFLX (6 years) vs VIVAX (32 years). LVFLX (1.63) is less costly to investors than VIVAX (0.17). LVFLX is a more actively managed with annual turnover of: 58.00 vs. VIVAX (10.00). LVFLX has a lower initial minimum investment than VIVAX: LVFLX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 0.72 vs. LVFLX (-0.77). VIVAX return over 5 years is better than : 64.30 vs. LVFLX (13.48).
LVFLXVIVAXLVFLX / VIVAX
Total Expense Ratio0.670.17394%
Annual Report Gross Expense Ratio1.630.17959%
Fund Existence6 years32 years-
Gain YTD-7.652-5.712134%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets31.8M191B0%
Annual Yield % from dividends0.912.1442%
Returns for 1 year-0.770.72-107%
Returns for 3 years-17.658.14-217%
Returns for 5 years13.4864.3021%
Returns for 10 yearsN/A88.68-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.440.02
+5.69%
Lyell Immunopharma
CPRX22.050.60
+2.80%
Catalyst Pharmaceuticals
INNV2.820.06
+2.17%
InnovAge Holding Corp
UHAL61.040.18
+0.30%
U-Haul Holding Company
NLSP1.35N/A
-0.01%
Nls Pharmaceutics Ltd